1-benzhydryl-4-[4-(1,2,4-triazol-1-yl)butyl]piperazine

ID: ALA5192792

Chembl Id: CHEMBL5192792

PubChem CID: 14986611

Max Phase: Preclinical

Molecular Formula: C23H29N5

Molecular Weight: 375.52

Associated Items:

Names and Identifiers

Canonical SMILES:  c1ccc(C(c2ccccc2)N2CCN(CCCCn3cncn3)CC2)cc1

Standard InChI:  InChI=1S/C23H29N5/c1-3-9-21(10-4-1)23(22-11-5-2-6-12-22)27-17-15-26(16-18-27)13-7-8-14-28-20-24-19-25-28/h1-6,9-12,19-20,23H,7-8,13-18H2

Standard InChI Key:  SMRZRKQKIZLRQY-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

P2RX7 Tchem P2X purinoceptor 7 (5534 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 375.52Molecular Weight (Monoisotopic): 375.2423AlogP: 3.47#Rotatable Bonds: 8
Polar Surface Area: 37.19Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.29CX LogP: 3.67CX LogD: 2.72
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.57Np Likeness Score: -1.53

References

1. Yamagiwa N, Komine M, Hanaoka F, Nobuta T, Yoshida K, Ito M, Matsuoka I..  (2022)  Exploratory study of oxatomide derivatives with high P2X7 receptor inhibitory activity.,  77  [PMID:36283612] [10.1016/j.bmcl.2022.129035]

Source